Insider: Carr Patricia SVP, Chief Accounting Officer - Jazz Pharmaceuticals plc
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 6,512 | 0 | 6,512 |
| Value | $1,226,014.24 | $0.00 | $1,226,014.24 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/09/2026 | DDS | 1,287 | Direct | COM | $182.94 | $235,443.78 | 6,512 |
| 02/27/2026 | DDS | 1,117 | Direct | COM | $190.91 | $213,243.45 | 9,235 |
| 02/26/2026 | DDS | 1,253 | Direct | COM | $194.11 | $243,222.21 | 10,352 |
| 12/05/2025 | DDS | 160 | Direct | COM | $171.11 | $27,377.60 | 7,012 |
| 12/05/2025 | DDS | 4,500 | Direct | COM | $171.20 | $770,405.40 | 7,012 |
| 11/18/2025 | DDS | 5,250 | Direct | COM | $182.07 | $955,867.50 | 7,012 |
| 11/18/2025 | DDS | 69 | Direct | COM | $181.66 | $12,534.54 | 7,012 |
| 03/10/2025 | DDS | 1,140 | Direct | COM | $137.81 | $157,103.40 | 7,012 |
| 02/28/2025 | DDS | 773 | Direct | COM | $143.30 | $110,767.04 | 9,485 |
| 02/27/2025 | DDS | 313 | Direct | COM | $144.42 | $45,202.27 | 8,237 |
| 02/27/2025 | DDS | 4,500 | Direct | COM | $144.42 | $649,872.90 | 8,237 |
| 12/02/2024 | DDS | 53 | Direct | COM | $122.49 | $6,491.97 | 6,596 |
| 06/07/2024 | DDS | 163 | Direct | COM | $108.83 | $17,738.48 | 6,596 |
| 03/07/2024 | DDS | 1,768 | Direct | COM | $116.98 | $206,820.64 | 6,596 |
| 03/06/2024 | DDS | 700 | Direct | COM | $117.51 | $82,257.00 | 8,364 |
| 03/06/2024 | DDS | 1,236 | Direct | COM | $120.85 | $149,370.60 | 9,064 |
| 08/29/2023 | DDS | 142 | Direct | COM | $143.47 | $20,372.54 | 5,986 |
| 08/14/2023 | DDS | 158 | Direct | COM | $138.16 | $21,828.89 | 6,128 |
| 06/07/2023 | DDS | 126 | Direct | COM | $127.92 | $16,117.42 | 6,286 |
| 03/15/2023 | DDS | 1,023 | Direct | COM | $133.22 | $136,284.06 | 6,286 |
| 03/05/2023 | DDS | 1,148 | Direct | COM | $140.76 | $161,593.86 | 7,309 |
| 12/05/2022 | DDS | 63 | Direct | COM | $152.06 | $9,579.98 | 5,934 |
| 08/15/2022 | DDS | 142 | Direct | COM | $156.86 | $22,274.12 | 5,934 |
| 08/15/2022 | DDS | 2,000 | Direct | COM | $160.29 | $320,580.00 | 5,934 |
| 08/08/2022 | DDS | 158 | Direct | COM | $152.33 | $24,067.43 | 6,076 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research